文献速递脑血管病

伊比利亚美洲卒中护理与溶栓应用:SITS-SIECV登记报告

Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register.
PubMed 文献 · Stroke · 2019-08-06

结果显示静脉溶栓率7.7%,溶栓后症状性颅内出血率5.7%,3个月独立比例溶栓与未溶栓者相近。

要点

  • 伊比利亚美洲卒中登记中静脉溶栓率为7.7%。
  • 溶栓患者症状性颅内出血率为5.7%。
  • 3个月独立比例溶栓者60.3% vs 未溶栓者59.1%。

核心结论

  • SITS-SIECV是伊比利亚美洲最大的普通卒中人群登记,首次评估该地区静脉溶栓使用水平。

主要发现

  • 最常见危险因素为高血压(71.3%)、血脂异常(35.2%)和糖尿病(23.6%),房颤占15.1%。
  • 溶栓后症状性颅内出血率5.7%;3个月独立(mRS 0–2)比例溶栓者60.3% vs 未溶栓者59.1%。
  • 3个月死亡率溶栓者11.4% vs 未溶栓者12.8%。

临床怎么用

  • 该登记数据可用于评估伊比利亚美洲卒中护理质量并指导改进。
  • 静脉溶栓率7.7%提示该地区溶栓应用有待提升。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Standardized registries may provide valuable data to further improve stroke care. Our aim was to obtain updated information about characteristics of stroke patients and management of stroke across the Ibero-American countries, using a common in-hospital registry (Safe Implementation of Treatments in Stroke–Sociedad Iberoamericana de Enfermedades Cerebrovasculares) as a basis for further quality improvement. METHODS: Data for this study were entered into the Safe Implementation of Treatments in Stroke registry from September 2009 to December 2013 by 58 centers in 14 countries. Data included demographics, risk factors, onset-to-door time, National Institutes of Health Stroke Scale score, stroke subtype, ischemic stroke etiology, treatments, 3-month mortality, and modified Rankin Scale score. Time to treatment was also recorded for patients treated with thrombolysis. RESULTS: Five thousand four hundred one patients were registered; median age, 65 years; 46% women; 3915 (72.5%) ischemic strokes; 686 (13.7%) hemorrhagic strokes; 213 (4.3%) subarachnoid hemorrhages; 414 (8.3%) transient ischemic attacks; and 31 (0.6%) cerebral vein thrombosis. The most prevalent risk factors were hypertension (71.3%), dyslipidemia (35.2%), and diabetes mellitus (23.6%). Atrial fibrillation was present in 15.1%. Three hundred one ischemic strokes were treated with intravenous thrombolysis (IVT; 7.7%). Patients undergoing IVT were more severely affected (median baseline National Institutes of Health Stroke Scale score, 11 versus 6). The rate of symptomatic intracerebral hemorrhages after IVT was 5.7%. At 3 months, 60.3% of IVT-treated patients and 59.1% of untreated patients were independent (modified Rankin Scale score, 0–2). Mortality was 11.4% in treated and 12.8% in untreated patients. CONCLUSIONS: Safe Implementation of Treatments in Stroke–Sociedad Iberoamericana de Enfermedades Cerebrovasculares is the largest registry of a general stroke population and the first study to evaluate the level of IVT use in Ibero-America. It provides valuable information that may help to improve the quality of stroke care in the Ibero-American region.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Alonso de Leciñana M, Mazya MV, Kostulas N, et al. Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register. Stroke. 2019. PMID: 31670921. doi:10.1161/STROKEAHA.119.025668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。